http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005214763-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_870832d1e91e735015b1f7a4395b6084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f3109befbff2bcd31b2339d5610e0ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ff1e5075983f577f494dc996fc6fb03 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2003-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2430e4d367f9e159f6c81d4a24c4a11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed173883a01a487397f986879412936c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a73b0f942cdb72221ebecdd6ffa6f863 |
| publicationDate | 2005-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2005214763-A1 |
| titleOfInvention | Diagnostic and therapeutic use of an activator protein for vesicle secretion for neurodegenerative diseases |
| abstract | The present invention discloses the differential expression of the activator protein for vesicle secretion CAPS gene in specific brain regions of Alzheimer's disease patients. Based on this finding, this invention provides a method for diagnosing or prognosticating a neurodegenerative disease, in particular Alzheimer's disease, in a subject, or for determining whether a subject is at increased risk of developing such a disease. Furthermore, this invention provides therapeutic and prophylactic methods for treating or preventing Alzheimer's disease and related neurodegenerative disorders using a gene coding for an activator protein for vesicle secretion, in particular the CAPS gene and its corresponding gene products. A method of screening for modulating agents of neurodegenerative diseases is also disclosed. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006091964-A3 |
| priorityDate | 2002-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 476.